BioAge Labs, Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +33.6% | -6.1% | +12.7% | -56.9% | -59.1% | -8.8% | +1,281.9% | -17.7% | |
| – | -39.9% | -81.0% | +189.8% | -51.5% | +83.8% | -9.7% | +1,311.1% | -19.7% | |
| – | -39.0% | -86.3% | +131.7% | -71.3% | +496.8% | -21.7% | +1,537.2% | -46.7% | |
| – | -39.0% | -86.3% | +131.7% | -71.3% | +496.8% | -21.7% | +1,537.2% | -20.7% | |
| – | -36.8% | +105.2% | +0.8% | +392.9% | – | – | – | – | |
| – | -25.4% | -2.9% | +157.1% | +7.2% | – | – | – | – | |
| – | -9.7% | +0.0% | +0.0% | – | – | – | – | – | |
| – | +4.2% | +46.6% | -3.5% | -34.1% | – | – | – | – | |
| – | +93.4% | +1.9% | +16.7% | -57.8% | +195.8% | +41.4% | -82.4% | -34.9% | |
| – | +28.6% | +29.6% | +52.6% | -75.1% | -48.1% | +892.5% | -52.3% | -27.5% | |
| – | -54.3% | +245.8% | +126.3% | -78.9% | -95.6% | +20,756.9% | -86.2% | -47.9% | |
| – | +3,234.1% | +1,510.0% | -62.0% | +2.2% | -63.3% | -17.5% | +7.0% | +34.0% | |
| – | – | – | – | – | – | +264.2% | -69.5% | – | |
| – | -11.5% | -19.4% | +4.6% | -54.9% | -615.1% | – | – | -15.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +21.3% | +22.7% | -18.5% | +0.1% | +4.8% | +0.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.